高级搜索
孔天东, 陈露, 段方方, 王留晏, 周寒丽, 赵晓丽, 刘萌萌, 刘丹娜. CD8+T淋巴细胞浸润与三阴性乳腺癌新辅助化疗疗效的关系[J]. 肿瘤防治研究, 2021, 48(5): 484-488. DOI: 10.3971/j.issn.1000-8578.2021.20.1191
引用本文: 孔天东, 陈露, 段方方, 王留晏, 周寒丽, 赵晓丽, 刘萌萌, 刘丹娜. CD8+T淋巴细胞浸润与三阴性乳腺癌新辅助化疗疗效的关系[J]. 肿瘤防治研究, 2021, 48(5): 484-488. DOI: 10.3971/j.issn.1000-8578.2021.20.1191
KONG Tiandong, CHEN Lu, DUAN Fangfang, WANG Liuyan, ZHOU Hanli, ZHAO Xiaoli, LIU Mengmeng, LIU Danna. Relation Between CD8+T Lymphocyte Infiltration and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2021, 48(5): 484-488. DOI: 10.3971/j.issn.1000-8578.2021.20.1191
Citation: KONG Tiandong, CHEN Lu, DUAN Fangfang, WANG Liuyan, ZHOU Hanli, ZHAO Xiaoli, LIU Mengmeng, LIU Danna. Relation Between CD8+T Lymphocyte Infiltration and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer[J]. Cancer Research on Prevention and Treatment, 2021, 48(5): 484-488. DOI: 10.3971/j.issn.1000-8578.2021.20.1191

CD8+T淋巴细胞浸润与三阴性乳腺癌新辅助化疗疗效的关系

Relation Between CD8+T Lymphocyte Infiltration and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

  • 摘要:
    目的 探讨三阴性乳腺癌组织CD8+T淋巴细胞浸润(CD8+Tils)的特点与患者预后的关系。
    方法 回顾性分析术前行新辅助化疗的126例三阴性乳腺癌患者的临床病理资料,采用免疫组织化学法分析CD8+Tils与临床病理特征的关系;Kaplan-Meier法绘制生存曲线,Cox风险比例回归模型分析患者无病生存时间(DFS)的预后影响因素。
    结果 高密度CD8+Tils浸润与年龄 < 60岁、病理高分级、临床高分期显著相关(P < 0.05)。CD8+Tils高密度浸润患者术后pCR率较低密度组高(66.7% vs. 19.8%, P=0.000)。高密度组中位DFS显著长于CD8+Tils低密度组(49 vs. 25月, P < 0.05)。多因素分析显示病理高分级、肿瘤直径 > 2 cm、淋巴结转移、脉管侵犯、CD8+Tils低密度浸润均为预后不良影响因素(P < 0.05),CD8+Tils为独立预后因素。
    结论 CD8+Tils有可能是三阴性乳腺癌患者独立预后指标,高密度浸润患者术后pCR率高、DFS长、远期疗效更优。

     

    Abstract:
    Objective To investigate the relation between the characteristics of CD8+T lymphocyte infiltration and the prognosis of triple-negative breast cancer patients.
    Methods We retrospectively analyzed the clinicopathological data of 126 patients with triple-negative breast cancer undergoing preoperative neoadjuvant chemotherapy. Immunohistochemical staining was used to analyze the relation between CD8+T lymphocyte infiltration and clinicopathological characteristics. Kaplan-Meier method was used to draw the survival curve, and Cox risk ratio regression model was used to analyze the prognostic factors affecting disease-free survival time (DFS).
    Results High-density CD8+Tils was associated with age < 60 years old, high pathological grade and high clinical stage (P < 0.05). The pCR rate of high-density CD8+Tils group was higher than that of the low-density group (66.7% vs. 19.8%, P=0.000). The median DFS of the high-density group was significantly longer than that of the low-density group (49 vs. 25 months, P < 0.05). Multivariate analysis showed that high pathological grade, tumor diameter > 2 cm, lymph node metastasis, vascular invasion and CD8+Tils low-density infiltration were factors for poor prognosis (P < 0.05), and CD8+Tils was an independent prognostic factor.
    Conclusion CD8+Tils may be an independent prognostic indicator for triple-negative breast cancer. The patients with high-density infiltration have high postoperative pCR rate, long DFS and better long-term efficacy.

     

/

返回文章
返回